The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Get the basics on what healthcare supply chain and manufacturers, together with clinical and IT departments, must do to implement the Unique Device
Podcasts
In this three-part webcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
On-Demand Educational Webinars
This session explains the benefits of implementing the UDI such as immediate device status updates through collaboration with manufacturers and…
Book
AHRMM created this book for engaged and motivated supply chain leaders in the making.
On-Demand Educational Webinars
The perioperative services administration at Massachusetts General created a rigorous and rapid approach to raising the level of cost awareness among…
On-Demand Educational Webinars
Outsourcing of hospital functions is a common and growing practice in the U.S. and comprises on average 25% of total non-labor spend in hospitals.…